At the last Influenza Summit, part of World Vaccine Congress Asia, Prof.Dr. Xu Fei of Changchun BCHT Biotechnology Co. gave the following presentation entitled:
Live attenuated influenza vaccine (LAIV) and its clinical development in China.
Some points discussed during the presentation include:
- BCHT overview
- LAIV introduction
- Review of Clinical Data
- Development of clinical trial strategy in China
If you find this presentation informative and interesting, you might want to attend World Vaccine Congress Asia 2014 happening from 9-11 June in Singapore. Visit our website to book your tickets today!